PMID- 31902927 OWN - NLM STAT- MEDLINE DCOM- 20201109 LR - 20201109 IS - 1347-5215 (Electronic) IS - 0918-6158 (Linking) VI - 43 IP - 1 DP - 2020 TI - Multiple Biological Aspects of Eosinophils in Host Defense, Eosinophil-Associated Diseases, Immunoregulation, and Homeostasis: Is Their Role Beneficial, Detrimental, Regulator, or Bystander? PG - 20-30 LID - 10.1248/bpb.b19-00892 [doi] AB - Eosinophils are innate immune leukocytes and play important roles as terminal effector cells owing to their mediators, such as tissue-destructive cationic proteins, cytokines, chemokines, and lipid mediators. Historically, they are not only considered an important player in host defense against parasitic, viral, fungal, and bacterial infections but also implicated in the pathogenesis of eosinophil-associated diseases, such as allergic rhinitis, asthma, eosinophilic chronic rhinosinusitis, esophagitis, atopic dermatitis, myopathies, and hypereosinophilic syndrome. Moreover, recent studies have shown that eosinophils have an immune regulatory and homeostatic function. Interestingly, there is emerging evidence that eosinophils are accumulated through adoptive T-helper 2 (Th2) and innate Th2 responses, mechanisms of the classical allergen-specific immunoglobulin E (IgE)-mediated response, and group 2 innate lymphoid cell-derived interleukin-5, respectively. Furthermore, in agreement with current concepts of eosinophil subtypes, it has been shown that resident and phenotypically distinct eosinophils, i.e., resident and recruited inflammatory eosinophils, exist in inflamed sites, and each has different functions. Thus, the classical and novel studies suggest that eosinophils have multiple functions, and their roles may be altered by the environment. In this article, we review multiple biological aspects of eosinophils (novel and classical roles), including their beneficial and detrimental effects, immunoregulation, and homeostatic function. FAU - Kanda, Akira AU - Kanda A AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. AD - Allergy Center, Kansai Medical University. FAU - Yasutaka, Yun AU - Yasutaka Y AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. FAU - Van Bui, Dan AU - Van Bui D AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. FAU - Suzuki, Kensuke AU - Suzuki K AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. FAU - Sawada, Shunsuke AU - Sawada S AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. FAU - Kobayashi, Yoshiki AU - Kobayashi Y AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. AD - Allergy Center, Kansai Medical University. FAU - Asako, Mikiya AU - Asako M AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. AD - Allergy Center, Kansai Medical University. FAU - Iwai, Hiroshi AU - Iwai H AD - Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University. LA - eng PT - Journal Article PT - Review PL - Japan TA - Biol Pharm Bull JT - Biological & pharmaceutical bulletin JID - 9311984 SB - IM MH - Animals MH - Eosinophils/*immunology MH - Homeostasis MH - Humans MH - Immunomodulation MH - Infections/immunology MH - Inflammation/immunology OTO - NOTNLM OT - allergic rhinitis (AR) OT - asthma OT - eosinophil OT - eosinophilic chronic rhinosinusitis (ECRS) EDAT- 2020/01/07 06:00 MHDA- 2020/11/11 06:00 CRDT- 2020/01/07 06:00 PHST- 2020/01/07 06:00 [entrez] PHST- 2020/01/07 06:00 [pubmed] PHST- 2020/11/11 06:00 [medline] AID - 10.1248/bpb.b19-00892 [doi] PST - ppublish SO - Biol Pharm Bull. 2020;43(1):20-30. doi: 10.1248/bpb.b19-00892.